Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC) today announced that the
U.S. Food and Drug Administration (FDA) has approved the New Drug
Application for KERYDIN™ (tavaborole) topical solution, 5%, the first
oxaborole antifungal approved for the topical treatment of onychomycosis
of the toenails.
for FDA Approves Anacor Pharmaceuticals’ KERYDIN™ (Tavaborole) Topical Solution, 5% for the Treatment of Onychomycosis of the Toenails investment picks